Skip to main content

JPMORGAN CHASE & CO

Position in RIGL — Rigel Pharmaceuticals Inc

CIK 19617 NEW YORK, NY

Position in RIGL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,630,325
+$519,416 QoQ
Shares Held
41,675
+1.4% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#54
of 156 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 82% Shared 0% None 18%

Common Shares in RIGL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. RIGL ranks #161 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RIGL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,630,325 41,675
2026-03-31 $1,110,909 41,084
2025-12-31 $1,585,308 37,014
2025-09-30 $990,416 34,960
2025-06-30 $186,305 9,947
2025-03-31 $997,130 55,427
2024-12-31 $3,035,873 180,492
2024-09-30 $424,529 26,238
2024-06-30 $148,764 18,098
2024-03-31 $152,014 102,713
2023-12-31 $185,916 128,219
2023-09-30 $231,175 214,053
2023-06-30 $349,645 271,043
2023-03-31 $689,708 522,507
2022-12-31 $257,561 171,708
2022-09-30 $152,236 129,015
2022-06-30 $106,816 94,529
2022-03-31 $284,269 95,074
2021-12-31 $200,598 75,698
2021-09-30 $276,688 76,223
2021-06-30 $322,794 74,377
2021-03-31 $219,112 64,068
2020-12-31 $2,033,465 580,990
2020-09-30 $152,028 63,345
2020-06-30 $739,573 404,139
2020-03-31 $989,651 634,392